Pharmacology of proton pump inhibitors

被引：379

作者：

Shin J.M. ^{[1
]}

Sachs G. ^{[1
]}

机构：

[1] Membrane Biology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90073

来源：

Current Gastroenterology Reports | 2008年 / 10卷 / 6期

关键词：

Omeprazole; Proton Pump Inhibitor; Acid Secretion; Lansoprazole; Parietal Cell;

D O I：

10.1007/s11894-008-0098-4

中图分类号：

学科分类号：

摘要：

The gastric H,K-ATPase is the primary target for the treatment of acid-related diseases. Proton pump inhibitors (PPIs) are weak bases composed of two moieties, a substituted pyridine with a primary pKa of about 4.0, which allows selective accumulation in the secretory canaliculus of the parietal cell, and a benzimidazole with a second pKa of about 1.0. PPIs are acid-activated prodrugs that convert to sulfenic acids or sulfenamides that react covalently with one or more cysteines accessible from the luminal surface of the ATPase. Because of covalent binding, their inhibitory effects last much longer than their plasma half-life. However, the short half-life of the drug in the blood and the requirement for acid activation impair their efficacy in acid suppression, particularly at night. PPIs with longer half-life promise to improve acid suppression. All PPIs give excellent healing of peptic ulcers and produce good results in reflux esophagitis. PPIs combined with antibiotics eradicate Helicobacter pylori. © Springer Science+Business Media, LLC 2008.

引用

页码：528 / 534

页数：6

共 63 条

[1]

Forte J.G., Forte T.M., Black J.A., Et al., Correlation of parietal cell structure and function, J Clin Gastroenterol, 5, SUPPL. 1, pp. 17-27, (1983)

[2]

Sawaguchi A., Aoyama F., Ide S., Et al., The cryofixation of isolated rat gastric mucosa provides new insights into the functional transformation of gastric parietal cells: An in vitro experimental model study, Arch Histol Cytol, 68, pp. 151-160, (2005)

[3]

Sachs G., Chang H.H., Rabon E., Et al., A nonelectrogenic H+ pump in plasma membranes of hog stomach, J Biol Chem, 251, pp. 7690-7698, (1976)

[4]

Shull G.E., Lingrel J.B., Molecular cloning of the rat stomach (H++ K+)- ATPase, J Biol Chem, 261, pp. 16788-16791, (1986)

[5]

Maeda M., Ishizaki J., Futai M., cDNA cloning and sequence determination of pig gastric (H++ K+)-ATPase, Biochem Biophys Res Commun, 157, pp. 203-209, (1988)

[6]

Bamberg K., Mercier F., Reuben M.A., Et al., cDNA cloning and membrane topology of the rabbit gastric H+/K+-ATPase alpha-subunit, Biochim Biophys Acta, 1131, pp. 69-77, (1992)

[7]

Song I., Mortell M.P., Gantz I., Et al., Molecular cloning and structural analysis of canine gastric H+, K+-ATPase, Biochem Biophys Res Commun, 196, pp. 1240-1247, (1993)

[8]

Maeda M., Oshiman K., Tamura S., Et al., Human gastric (H++K+)-ATPase gene. Similarity to (Na++K+)-ATPase genes in exon/intron organization but difference in control region, J Biol Chem, 265, pp. 9027-9032, (1990)

[9]

Rabon E.C., McFall T.L., Sachs G., The gastric [H,K]ATPase: H+/ATP stoichiometry, J Biol Chem, 257, pp. 6296-6299, (1982)

[10]

Munson K., Garcia R., Sachs G., Inhibitor and ion binding sites on the gastric H,K-ATPase, Biochemistry, 44, pp. 5267-5284, (2005)

← 1 2 3 4 5 6 7 →